JP2023517641A5 - - Google Patents
Info
- Publication number
- JP2023517641A5 JP2023517641A5 JP2022554677A JP2022554677A JP2023517641A5 JP 2023517641 A5 JP2023517641 A5 JP 2023517641A5 JP 2022554677 A JP2022554677 A JP 2022554677A JP 2022554677 A JP2022554677 A JP 2022554677A JP 2023517641 A5 JP2023517641 A5 JP 2023517641A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- use according
- clinical
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900743A AU2020900743A0 (en) | 2020-03-11 | Method for treating inflammatory bowel disease II | |
| AU2020900743 | 2020-03-11 | ||
| PCT/EP2021/056193 WO2021180851A1 (en) | 2020-03-11 | 2021-03-11 | Method for treating inflammatory bowel disease ii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517641A JP2023517641A (ja) | 2023-04-26 |
| JP2023517641A5 true JP2023517641A5 (enExample) | 2024-03-13 |
Family
ID=74884938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554677A Pending JP2023517641A (ja) | 2020-03-11 | 2021-03-11 | 炎症性腸疾患を治療するための方法ｉｉ |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230104108A1 (enExample) |
| EP (1) | EP4117623A1 (enExample) |
| JP (1) | JP2023517641A (enExample) |
| KR (1) | KR20220152240A (enExample) |
| CN (1) | CN115297875A (enExample) |
| AU (1) | AU2021235055A1 (enExample) |
| BR (1) | BR112022018022A2 (enExample) |
| CA (1) | CA3170918A1 (enExample) |
| WO (1) | WO2021180851A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070258963A1 (en) | 2006-01-13 | 2007-11-08 | Osiris Therapeutics, Inc. | Mesenchymal stem cells expressing TNF-alpha receptors |
| US20120087868A1 (en) | 2010-10-08 | 2012-04-12 | Gabriele Todd | Nanoparticle-loaded cells |
| SG11202004680UA (en) | 2017-11-22 | 2020-06-29 | Mesoblast Int Sarl | Cellular compositions and methods of treatment i |
| WO2021180850A1 (en) * | 2020-03-11 | 2021-09-16 | Mesoblast International Sàrl | Method for treating inflammatory bowel disease i |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
| US20070026377A1 (en) * | 2000-02-10 | 2007-02-01 | The Regents Of The University Of California | Methods for preserving nucleated mammalian cells |
| US8465733B2 (en) * | 2007-11-02 | 2013-06-18 | Jcr Pharmaceuticals Co., Ltd. | Pharmaceutical composition containing human mesenchymal stem cell |
| CN104873542A (zh) * | 2015-05-21 | 2015-09-02 | 北京青藤谷禧干细胞科技研究院有限公司 | 一种脐带间充质干细胞注射液及其制备方法和应用 |
| EP3419635B1 (en) * | 2016-02-22 | 2022-01-05 | Centauri Biotech, S.L. | Pharmaceutical or veterinary cell compositions comprising mesenchymal stromal cells (mscs) and dimethyl sulfoxide (dmso) |
| GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| WO2018002930A1 (en) * | 2016-06-30 | 2018-01-04 | Stem Cell Medicine Ltd. | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| WO2018182612A1 (en) * | 2017-03-30 | 2018-10-04 | Progenity Inc. | Methods and ingestible devices for the regio-specific release of stem cells at the site of gastrointestinal tract disease |
| WO2021180850A1 (en) * | 2020-03-11 | 2021-09-16 | Mesoblast International Sàrl | Method for treating inflammatory bowel disease i |
-
2021
- 2021-03-11 WO PCT/EP2021/056193 patent/WO2021180851A1/en not_active Ceased
- 2021-03-11 AU AU2021235055A patent/AU2021235055A1/en active Pending
- 2021-03-11 EP EP21712450.2A patent/EP4117623A1/en active Pending
- 2021-03-11 CA CA3170918A patent/CA3170918A1/en active Pending
- 2021-03-11 KR KR1020227032830A patent/KR20220152240A/ko active Pending
- 2021-03-11 CN CN202180020526.4A patent/CN115297875A/zh active Pending
- 2021-03-11 US US17/906,150 patent/US20230104108A1/en active Pending
- 2021-03-11 BR BR112022018022A patent/BR112022018022A2/pt unknown
- 2021-03-11 JP JP2022554677A patent/JP2023517641A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517641A5 (enExample) | ||
| Petagna et al. | Pathophysiology of Crohn’s disease inflammation and recurrence | |
| Sorrentino et al. | Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease | |
| JP2023517636A5 (enExample) | ||
| Sugimura et al. | Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet’s disease | |
| Piotrowicz et al. | The effects of hyperbaric treatment on perianal fistula activity in patients with Crohn’s disease | |
| Korenblit et al. | Idiopathic myointimal hyperplasia of the mesenteric veins | |
| RU2364405C1 (ru) | Способ лечения воспалительных заболеваний кишечника | |
| EP3797772B1 (en) | Rebamipide for use in prevention and treatment of crohn's disease | |
| Polyakov et al. | Surgical treatment of the stricture of the lower third of ureter after radiation therapy of pelvic organs | |
| Casserly et al. | Reversible bilateral hydronephrosis without obstruction in hepatitis B–associated polyarteritis nodosa | |
| Nanduri et al. | Radiation injury in the gastrointestinal tract | |
| Tanaka et al. | S80 Strategies for the Treatment of Dysplasia at an Institution in Japan | |
| Zuhdi et al. | S79 Symptomatic Bradycardia: A Rarely Reported Manifestation of Crohn’s Disease Flare-up and Mesalamine Use | |
| Hu et al. | Effect of vascular root lymph node dissection combined with ligation at different sites to preserve the left colonic artery on the early outcome, immune function and prognosis of patients with rectal cancer | |
| Yüksel et al. | Treatment of tuberculous ureteritis. What is the appropriate time for invasive treatment? A case report and review of literature | |
| Shahid et al. | 2089 Psoriasis Induced by Infliximab Treatment in a Young Patient With Crohn’s Disease | |
| Zakharova et al. | Polyarteriitis Nodosa with Real Arteries and Vein Involvement and Uroligical Manifestations: Case Report | |
| Davies | The small intestine | |
| Baid et al. | 3150 Deep Venous Thrombosis in Ulcerative Colitis | |
| Ali et al. | S3938 De Novo Ulcerative Colitis in a Patient with Rapidly Progressive Glomerulonephritis (RPGN) after Renal Transplant | |
| Baili et al. | A Rare Manifestation of Crohn's Disease: Sinonasal Granulomatosis. Report of a Case and Review of Literature | |
| Gallagher et al. | 2073 A Rare Case of S. Constellatus Bacteremia Secondary to a Perianal Abscess in an Individual With Crohn's Disease | |
| RU2477478C1 (ru) | Способ оценки эффективности лечения воспалительных заболеваний кишечника | |
| O'Morain et al. | P463 Long-term effects of anti-TNF therapy on bone metabolism |